Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
Schlueter, Max, Finn, Elaine, Díaz, Silvia, Dilla, Tatiana, Inciarte-Mundo, José, Fakhouri, WalidVolume:
Volume 11
Language:
english
Journal:
ClinicoEconomics and Outcomes Research
DOI:
10.2147/CEOR.S201621
Date:
June, 2019
File:
PDF, 581 KB
english, 2019